NDC 65113-8503

NuGLOW DAYTIME THERAPY With SPF 15

Avobenzone, Octinoxate, And Zinc Oxide

NuGLOW DAYTIME THERAPY With SPF 15 is a Topical Cream in the Human Otc Drug category. It is labeled and distributed by G.s. Cosmeceutical Usa, Inc.. The primary component is Avobenzone; Octinoxate; Zinc Oxide.

• Product ID: 65113-8503_f895144d-17fd-4efa-8b05-87f986871753
• NDC: 65113-8503
• Product Type: Human Otc Drug
• Proprietary Name: NuGLOW DAYTIME THERAPY With SPF 15
• Generic Name: Avobenzone, Octinoxate, And Zinc Oxide
• Dosage Form: Cream
• Route of Administration: TOPICAL
• Marketing Start Date: 2010-10-15
• Marketing Category: OTC MONOGRAPH NOT FINAL / OTC MONOGRAPH NOT FINAL
• Application Number: part352
• Labeler Name: G.S. COSMECEUTICAL USA, INC.
• Substance Name: AVOBENZONE; OCTINOXATE; ZINC OXIDE
• Active Ingredient Strength: 1 g/100g; g/100g; g/100g
• NDC Exclude Flag: E
• Listing Certified Through: 2017-12-31

Packaging

NDC 65113-8503-3

34 g in 1 JAR (65113-8503-3)

• Marketing Start Date: 2010-10-15
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 65113-8503-3 [65113850303]

NuGLOW DAYTIME THERAPY With SPF 15 CREAM

• Marketing Category: OTC MONOGRAPH NOT FINAL
• Application Number: part352
• Product Type: HUMAN OTC DRUG
• Marketing Start Date: 2010-10-15
• Inactivation Date: 2019-10-29

Drug Details

Active Ingredients

Ingredient	Strength
AVOBENZONE	1 g/100g

OpenFDA Data

• SPL SET ID: 5636a6e4-0747-41a6-9308-fd734784a2e2
• Manufacturer:
  • G.S. COSMECEUTICAL USA, INC.
• UNII:
  • G63QQF2NOX
  • 4Y5P7MUD51
  • SOI2LOH54Z